Sentence examples for protein in the case of from inspiring English sources

In each instance a raw food item, such as cucumbers in the case of pickles or milk protein in the case of cheeses, is inoculated with microorganisms known to produce the changes required for a desirable product.

The protein (in the case of MDrand, see Figure 2) or hPS-CT 4 complexes (all other MD runs) were placed in a rectangular box filled with ∼4000 SPC [36] water molecules.

Each of these has a direct impact on the abundance of messenger RNA (mRNA) (in the case of promoters and enhancers) and protein (in the case of miRNAs).

Fluorescent microscopy of cells expressing GFP-LC3 revealed diffuse localization of the fusion protein in the case of cells treated with DMSO (Fig.  3).

This process requires the transport of protein(s) across the membrane of the cell producing the protein (in the case of tsetse the ovarian follicle cells) and the membrane of the developing oocyte.

These biochemical marks can be as small as just a few atoms, such as methyl (Lys, Arg, Gln), acetyl (Lys), or phosphoryl groups (Ser, Thr), or as large as an entire protein in the case of ubiquitin or SUMO.

The driver mutations are hypothesized to be involved in either protein-protein interactions (in the case of Rad51D), protein-nucleic acid interaction (e.g., in CG33714), or allosteric regulation (e.g., in HDAC4).

The peptides can come from extracellular proteins in the case of dendritic cells, a process called cross-presentation.

Relative quantification of proteins in the case of iTRAQ was performed on the MS/MS scans and is the ratio of the areas under the peaks at 114, 115, 116, and 117 Da which represents the masses of the tags that correspond to the iTRAQ reagents.

To ascertain whether increased O-GlcNAc modification of some proteins in the case of PHB mutants (Ty114Phe and Tyr259Phe) is due to increased OGT activity, in vitro O-GlcNAc assays were performed using immunoprecipitated OGT from insulin treated cells co-transfected with OGT and wild type PHB or tyrosine (Tyr114 and Tyr259) mutant-PHB.

The two major lesions in AD are caused by distinct proteins, tau in the case of the neurofibrillary tangles and amyloid β-protein in the case of amyloid plaques.